Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients

British Journal of Anaesthesia

Volumn 102, Issue 5, 2009, Pages 597-607

  Suttner, S ^a   Boldt, J ^a   Mengistu, A ^a   Lang, K ^a   Mayer, J ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Complications, myocardial infarction; Heart, enoximone; Heart, esmolol; Hormones, B type natriuretic peptides; Surgery, vascular

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CISATRACURIUM; ENOXIMONE; ESMOLOL; FENTANYL; PHOSPHODIESTERASE III INHIBITOR; PROPOFOL; TROPONIN T; CARDIOTONIC AGENT; PHOSPHODIESTERASE III; PHOSPHODIESTERASE INHIBITOR; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ANESTHESIA; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HEART INDEX; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMIC MONITORING; HIGH RISK PATIENT; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MONOTHERAPY; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; SYSTEMIC VASCULAR RESISTANCE; VASCULAR SURGERY; ABDOMINAL AORTA; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG COMBINATION; HEART OUTPUT; METHODOLOGY; MIDDLE AGED; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AORTA, ABDOMINAL; CARDIAC OUTPUT; CARDIOTONIC AGENTS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENOXIMONE; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERIOPERATIVE CARE; PHOSPHODIESTERASE INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 66149108861     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep062     Document Type: Article

References (26)

1. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335: 1713-20
2. Poldermans D, Boersma E, Bax JJ, et al. The effects of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341: 1789-94
3. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-61
4. Noordzij PG, Poldermans D, Schouten O, et al. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery. Coron Artery Dis 2007; 18: 67-72
5. Feringa HH, Bax JJ, Boersma E, et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 2006; 114: I344-9
6. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-47
7. Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of b-adrenergic receptor subtype in perioperative medicine: mechanisms and sites of action. Br J Anaesth 2002; 88: 101-23
8. London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology 2004; 100: 170-5
9. VanDenKerkhof EG, Milne B, Parlow JL. Knowledge and practice regarding prophylactic perioperative beta blockade in patients undergoing noncardiac surgery: a survey of Canadian anesthesiologists. Anesth Analg 2003; 96: 1558-65
10. Warltier DC. b-adrenergic blocking drugs-incredibly useful, incredibly underutilized. Anesthesiology 1998; 88: 2-5
11. Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. Br J Anaesth 2006; 97: 799-807
12. Metra M, Nodari S, D'Aloia A, et al. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol 2002; 40: 1248-58
13. Shakar SF, Abraham WT, Gilbert EM, et al. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Coll Cardiol 1998; 31: 1336-40
14. Gunnicker M, Brinkmann M, Donovan TJ, Freund U, Schieffer M, Reidemeister JC. The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade. Thorac Cardiovasc Surg 1995; 43: 153-60
15. Harvey WR, Monk CR. A study of the combined haemodynamic effects of dobutamine and enoximone in patients taking beta adrenoceptor antagonists. Anaesth Intensive Care 1995; 23: 673-7
16. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9
17. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 102: 1193-209
18. De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-21
19. Boldt J, Brosch C, Lehmann A, Suttner S, Isgro F. The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 2004; 99: 1009-17
20. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative betablocker therapy: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2006; 113: 2662-74
21. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. Br Med J 2005; 331: 313-21
22. Biccard BM, Sear JW, Foëx P. Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. Br J Anaesth 2008; 100: 23-8
23. Carceles MD, Aleixandre F, Fuente T, Lopez-Vidal J, Laorden ML. Combined phosphodiesterase inhibition and beta-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat. Can J Anaesth 2001; 48: 486-92
24. Suttner S, Boldt J, Lang K, Mayer J, Röhm K, Piper SN. Continuous beta-block with esmolol in combination with enoximone: influence on cardiac function in high risk patients undergoing vascular surgery. Anaesthesist 2008; 57: 231-41
25. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999; 88: 477-82
26. Poldermans D, Bax JJ, Schouten O, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 2006; 48: 964-9